Read about Diagnostic Testing for PH
Diagnosing pulmonary hypertension (PH) in India presents unique challenges beyond the complexity of the disease itself. Some of these factors include:
Uneven distribution of specialists: Pulmonologists and cardiologists specializing in PH are concentrated in urban areas, leaving semi-urban and rural populations with limited access to accurate diagnosis and specialized care.
Financial constraints: High costs of diagnostic tests like echocardiograms and right heart catheterization can be prohibitive for many patients.
Lack of awareness: Limited awareness among healthcare professionals about the different types of PH and their specific diagnostic approaches can lead to misdiagnosis or delayed diagnosis.
Limited equipment availability: Access to advanced diagnostic tools like high-resolution CT scans and specialized lung function tests might be limited in some hospitals, impacting the accuracy of diagnosis.
Comorbidities: The presence of other conditions like chronic obstructive pulmonary disease (COPD) or sleep apnea can make differentiating PH from other causes more challenging.
Disease burden: India has a high burden of pulmonary diseases like tuberculosis and COPD, which can mimic some symptoms of PH, further complicating diagnosis.
Nutritional deficiencies: Nutritional deficiencies, common in certain populations in India, may complicate PH in some cases, adding a layer of complexity to the diagnostic process.
Genetic factors: Understanding the genetic predisposition to certain types of PH in specific populations within India is crucial for early diagnosis and management, but research in this area is ongoing.
Addressing these challenges through initiatives like increased specialist access, improved healthcare infrastructure, enhanced awareness, and ongoing research is crucial for improving the diagnosis and management of PH in India, ultimately leading to better patient outcomes.




